Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-01-30
2007-01-30
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C514S021800, C514S970000, C530S350000, C530S397000, C435S069100, C435S320100, C435S325000
Reexamination Certificate
active
09853731
ABSTRACT:
The present invention relates to a liquid pharmaceutical composition comprising an erythropoietin protein, a multiple charged inorganic anion in a pharmaceutically acceptable buffer suitable to keep the solution pH in the range from about 5.5 to about 7.0, and optionally one or more pharmaceutically acceptable excipients. This composition is especially useful for the prophylaxis and treatment of diseases related to erythropoiesis.
REFERENCES:
patent: 4732889 (1988-03-01), Cynshi et al.
patent: 4806524 (1989-02-01), Kawaguchi et al.
patent: 4992419 (1991-02-01), Woog et al.
patent: 5099003 (1992-03-01), Kotitschke et al.
patent: 5272135 (1993-12-01), Takruri
patent: 5354934 (1994-10-01), Pitt et al.
patent: 5460944 (1995-10-01), Franken et al.
patent: 5661125 (1997-08-01), Strickland
patent: 5716644 (1998-02-01), Zale et al.
patent: 5981707 (1999-11-01), Harrington et al.
patent: 6120761 (2000-09-01), Yamazaki et al.
patent: 6277367 (2001-08-01), Yamazaki et al.
patent: 6340742 (2002-01-01), Burg et al.
patent: 6372715 (2002-04-01), Kaltwasser et al.
patent: 6440932 (2002-08-01), Lehmann et al.
patent: 6586398 (2003-07-01), Kinstler et al.
patent: 6627187 (2003-09-01), Yamazaki et al.
patent: 6696056 (2004-02-01), Cheung et al.
patent: 6818613 (2004-11-01), Sharma et al.
patent: 2002/0115833 (2002-08-01), Burg et al.
patent: 2003/0092622 (2003-05-01), Sato et al.
patent: 2003/0104996 (2003-06-01), Li et al.
patent: 2004/0038878 (2004-02-01), Tanikawa et al.
patent: 2004/0147431 (2004-07-01), Papadimitriou
patent: 2004/0248797 (2004-12-01), Cheung et al.
patent: 41 35 542 (1993-04-01), None
patent: 0178665 (1986-04-01), None
patent: 0456153 (1991-11-01), None
patent: 539167 (1993-04-01), None
patent: 0640619 (1995-03-01), None
patent: 0909564 (1999-04-01), None
patent: 1232753 (2002-08-01), None
patent: 2171304 (1986-08-01), None
patent: WO-9206116 (1992-04-01), None
patent: WO 94/20069 (1994-09-01), None
patent: WO 94/28024 (1994-12-01), None
patent: WO 95/11924 (1995-05-01), None
patent: WO 96/40073 (1996-12-01), None
patent: WO 98/05363 (1998-02-01), None
patent: 00/24893 (2000-05-01), None
patent: WO 00/27419 (2000-05-01), None
patent: 01/07075 (2001-02-01), None
patent: WO 01/12155 (2001-02-01), None
patent: WO 03/020299 (2003-03-01), None
Hoffmann-la Roche Inc.
Johnston George W.
Kam Chih-Min
Rocha-Tramaloni Patricia S.
LandOfFree
Erythropoietin composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erythropoietin composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3758489